Prediction of Alzheimer's Pathological Changes in Subjective Cognitive Decline Using the Self-report Questionnaire and Neuroimaging Biomarkers

BACKGROUND AND PURPOSE: Subjective cognitive decline (SCD) may be the first symptomatic stage of Alzheimer's disease (AD). Hence, a screening tool to characterize the patients' complaints and assess the risk of AD is required. We investigated the SCD neuroimaging biomarker distributions an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Yun Jeong, Park, Kyung Won, Kang, Do-Young, Lee, Jae-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dementia Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494779/
https://www.ncbi.nlm.nih.gov/pubmed/31097969
http://dx.doi.org/10.12779/dnd.2019.18.1.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494779/
https://www.ncbi.nlm.nih.gov/pubmed/31097969
http://dx.doi.org/10.12779/dnd.2019.18.1.19

Ejemplares similares